Nath Bio-Genes Complete Financial Statements
NATHBIOGEN • Review detailed financials to uncover trends, confirm thesis & journal trades
4 Years of Data
2025 - 2022
Complete Financial Data Export
Export complete financial statements for Nath Bio-Genes (NATHBIOGEN).
Downloads include all available records across all periods.
For market performance, see the
NATHBIOGEN stock price today
.
Profitability Ratios
Net Profit Margin
6.25%
2025 data
EBITDA Margin
16.67%
2025 data
Operating Margin
9.00%
2025 data
Return on Assets
0.29%
2025 data
Return on Equity
0.47%
2025 data
Balance Sheet Ratios
Current Ratio
40.59
2025 data
Debt to Equity
1.59
2025 data
Equity Ratio
62.77%
2025 data
Asset Turnover
0.05
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+50.0%
Year-over-Year
Net Profit Growth
+200.0%
Year-over-Year
EBITDA Growth
+60.0%
Year-over-Year
Expense Growth
+48.1%
Year-over-Year
Assets Growth
+16.6%
Year-over-Year
Equity Growth
+5.6%
Year-over-Year
Liabilities Growth
+16.6%
Year-over-Year
Operating Cash Flow Growth
-76.0%
Year-over-Year
Investing Cash Flow Growth
+85.2%
Year-over-Year
Financing Cash Flow Growth
+75.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48 | 56 | 288 | 32 | 44 | 244 | 37 | 23 | 45 | 235 | 34 | 22 | 28 | 209 | 25 |
| Expenses | 40 | 52 | 245 | 27 | 39 | 207 | 29 | 18 | 41 | 198 | 26 | 17 | 137 | 175 | 20 |
| EBITDA | 8 | 5 | 42 | 5 | 5 | 37 | 9 | 5 | 4 | 37 | 8 | 5 | -109 | 35 | 6 |
| Operating Profit Margin % | 9.00% | 1.00% | 13.00% | 15.00% | 9.00% | 15.00% | 22.00% | 22.00% | 9.00% | 16.00% | 18.00% | 22.00% | -405.00% | 16.00% | 22.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 4 | 1 | 3 | 3 | 1 | 2 | 4 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 3 | 2 | 38 | 1 | 3 | 34 | 4 | 2 | 2 | 34 | 5 | 2 | -113 | 31 | 2 |
| Tax | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 4 | 0 | 1 |
| Net Profit | 3 | 2 | 37 | 1 | 3 | 33 | 3 | 2 | 1 | 33 | 4 | 2 | -116 | 31 | 1 |
| Earnings Per Share (₹) | 1.40 | 0.42 | 19.58 | 0.53 | 1.87 | 17.49 | 1.33 | 0.86 | 0.77 | 17.59 | 2.02 | 0.77 | -61.22 | 16.18 | 0.71 |
Related Pages for Nath Bio-Genes
Additional stock information and data for NATHBIOGEN
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 1,026 | 880 | 793 | 740 |
| Current Assets | 690 | 572 | 521 | 468 |
| Fixed Assets | 250 | 250 | 244 | 245 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 6 | 6 | 5 | 5 |
| Other Assets | 770 | 625 | 543 | 490 |
| LIABILITIES | ||||
| Total Liabilities | 1,026 | 880 | 793 | 740 |
| Current Liabilities | 17 | 8 | 3 | 3 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 644 | 610 | 573 | 542 |
| Share Capital | 19 | 19 | 19 | 19 |
| Reserves & Surplus | 625 | 591 | 554 | 523 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | 18 | 75 | 38 | 17 |
| Investing Activities | -4 | -27 | -3 | -20 |
| Financing Activities | -2 | -8 | -2 | -22 |
| Net Cash Flow | 12 | 39 | 34 | -25 |